Fairness opinions › Acquirers
Altaris: healthcare acquisitions with fairness opinions
4 public-company targets, 2018-2026, $2.0B combined enterprise value. The multiples Altaris paid and the banker analyses behind each target board's recommendation.
Deals
4
Median EV / EBITDA paid
16.8x
Median EV / revenue paid
1.84x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Simulations Plus | Altaris | Digital / HealthTech | $375M | 16.7x | 4.66x | 9.4%–11.4% | Morgan Stanley |
| 2024-06-21 | ShareCare | Altaris | Digital / HealthTech | $419M | 18.9x | 1.00x | 11.5%–12.5% | Houlihan Lokey, MTS Health Partners |
| 2022-02-28 | Intricon | Altaris | Medical Devices and Supplies | $236M | 16.8x | 1.64x | 12.1%–14.1% | |
| 2018-04-10 | Analogic | Altaris | Medical Devices and Supplies | $937M | 13.8x | 2.05x | 8.2%–9.4% |